Stemtech Corporation (QB) (STEK) Share Price

nic3

nice

Low float?

Does anyone know next earnings release on did one?

A lot to like here. Management with a successful track record. Great product. Great share structure. Traded on the QB. Great potential!

Golden cross confirmed!

appears some shorting going on today , or someone selling into the BID

IMO everybody will be talking about this company in the coming weeks. Everything looks good and the company has good communication with shareholders. They are releasing PRs very consistently. Everything an investor likes all in one place. Do your own DD, you might like this one.

Actually held strong today , lets see.

$STEK Volume back up , interest levels up, Revenue up , Price action
--
Superbowl Mgt Team
https://www.stemtech.com/us/en/Company/ManagementTeam
--
Solid news out
https://www.stemtech.com/us/en/Company/Investors?subnav=NAM
--
SEC Reporting and Financials Audited , OTC QB
STRONG Share Structure
https://www.otcmarkets.com/stock/STEK/security

its ready low floater

volume up looking good strong buy!

READY FOR MAJOR MOVE UP!!

STRONG BUY!!!

Good. Looks like they started to storm news now. It can go high with low volume.

Well, for all do your own DD , but Margie and Mike are well known for turn around situations and this was a ten dollar stock not to long ago
--
https://www.otcmarkets.com/stock/STEK/news/Stemtech-Corporation-Announces-Margie-and-Mike-Mares-Appointment-to-Field-Advisory-Board?id=385888
--
plus have a an out of this world shares structure
https://www.otcmarkets.com/stock/STEK/security
--
See finanicals on disclosure real business bringing in revenue and a QB stock

why is this moving? Is this beginning?

Ilike the addition to the team and set up here. lets see.

This is begining to"stek" to high heaven!!

This is begining to"stek" to high heaven!!

I am not well versed in this one.

I have no idea - I was kind of asking that myself.

Any chance this will go back up?

How about here at a $1?

News just hit related to interview with the CEO Mr Arnold.

$AAOI Strong breakout on the chart Friday..on watch next week..

https://stockcharts.com/c-sc/sc?s=AAOI&p=D&b=5&g=0&i=0&r=1663465013115

$STEK Interesting chart here..after huge fall off..looks very oversold and starting to rally..

https://stockcharts.com/c-sc/sc?s=STEK&p=D&b=5&g=0&i=0&r=1663464162757

New CEO interview just issued on Stemtech $STEK great info.
https://tradersnewssource. com/stek-interview/

Two bucks around the corner, shorts on the squeeze list of the day.

FOMO…

You will see $15 soon…

$STEK: Tapped $7.50.......... i know whats next



ITS $GXXY........... gonna run up to $7 like $STEK



GO $STEK

STEMTECH CORPORATION COMMENTS ON RECENT MARKET ACTIVITY

https://www.stocktitan.net/news/STEK/stemtech-corporation-comments-on-recent-market-hvjt1xvxc8rc.html

STEMTECH CORPORATION COMMENTS ON RECENT MARKET ACTIVITY
share:
Share on Facebook
Tweet on Twitter
Post to Reddit
July 13, 2022 - 3:00 pm
MIRAMAR, FL, July 13, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), was notified by OTC Markets at close of business Friday July 8th regarding a certain stock promotion which relates to our company’s stock. This press release is made by the Board to publicly comment on this Notice received by OTC Markets.

At close of business this past Friday, July 8th, OTC Markets notified our Company of a foreign stock promotion which we were unaware of, and provided Stemtech Corporation with a copy of an article from a UK web site called “World Finance”, which emphatically predicted share price appreciation in the Stem Cell arena in general, and our Company in particular. This promotion apparently based their material solely upon the past history of one of our Directors from publicly available material. Neither the Board nor our sole IR specialist, Winthorp Capital, have any knowledge of or involvement with said unknown third-party promotion; and would have remained ignorant of it but for the notice received from OTC Markets.

According to the copy of the promotion provided for review by OTCMarkets, the web site publishing the stock promotion was www.world-financial-times.com. The Company has reviewed said release and determined that the information posted was obtained from public information, the Company’s website and possibly certain filings by the Company with the SEC. The statements regarding the potential meteoric rise in our share price is specious and baseless, and by any objective standard should be ignored. In spite of the fact that the Company wholly disavows any knowledge of or connection to this release, the facts disclosed therein regarding our CEO’s business accomplishments are in fact accurate. Neither the Company or any its Officers or third-party consultants had any knowledge of, or were involved in any way, with this promotion.

The Company was queried as to the increased trading activity of July 8th, for which we have no explanation other than the possibility that this advertisement may have affected the market price.

After internal inquiry, there have been no sales or purchases of the company’s securities in the last 90 days by management, directors, officers, control persons, or any third-party service providers.

Regarding additional debt information requested by OTC Markets Group, the Company has issued several Convertible Notes that allow for a discount to current market rates at the time of issuance, as disclosed in our previous SEC filings, to wit:

At the time of the merger between this issuer and the new management in August, 2021, by agreement of all then existing debt holders and old management, all pre-existing debts were converted out to 6,000,000 shares, which equates to $0.09 per share. This was fully disclosed in our 8K of August 20th, 2021 and exhibits thereto.

As for currently existing debts, there are several Convertible Notes to two SIPC licensed Funds and several related people, none of which has been converted to date. These Notes include: 1) a Convertible Note of $568,182.00 to MCUS, LLC of 09/13/21; see our 8K filed 09/10/21. 2), a $455,555 Convertible Note to Leonite Fund I, LP of 09/01/21, see our 8K of 09/10/21. 3) A Convertible Note of $25,000 to our CEO Charles Arnold executed on 12/10/20, no call date, no interest, if converted to be at a 33% discount to market. 4) A $25,000 Convertible Note to our Independent Director Darryl Green of 12/10/20, no call date, no interest, if converted to be at a 33% discount to market. 5) A $100,000 Convertible Note to Greg Guy of 12/10/20, if converted to be at a 33% discount to market. 6) A $25,000 Convertible Note to our Independent Director Darryl Green of 01/07/21, if converted to be at a 33% discount to market.

In short, the Board of Directors wishes to emphatically clarify that neither it nor any of its officers, IR firm, controlling shareholders or any known affiliate have directly or indirectly been involved in any way, nor had any knowledge of this promotional piece. We wish to again to point out the last sentence of our “Forward Looking Statement” which is attached to every press release we issue -

“Stemtech Corporation would like to remind the investing public that the only announcements, filings or information about Stemtech Corporation which are condoned by the Company must emanate from the Company itself and bear our name as its source.”

What's going on here? Slowly being walked up old school stair step promo style.

$STEK: Going still............. $6.40


LOVE IT !!!!!!!!!


$TMNA is going to these levels in short time as well






GO $STEK

$STEK: Fantastic............ taps $6


Love this.


NO ONE WATCHING........... whatta sweet runner



GO $STEK

$STEK STEMTECH CORPORATION MOVES UP ON BUSINESS FOR HOME MOMENTUM RANK LISTPress Release | 04/28/2022

MIRAMAR, FL, April 28, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTC:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that it has been recognized as a company on the move in the Business For Home Momentum Rank List. The Momentum Rank List measures a variety of factors of leading companies in the Direct Selling industry to determine which companies in this niche are achieving positive momentum. The factors include, but are not limited to; activity rate, online visibility, growth, and relevance of the company.

Business For Home is a prominent publisher and authority in the Direct Selling industry, and publishes objective facts, figures and news related to the network marketing industry. According to Business For Home, their web site receives an estimated 10+ million international visitors, with the majority being Network Marketing professionals.

Stemtech moved up 108 places in the rankings from the previous year, to achieve a ranking of 159 out of a total of 722 of the top companies in the industry. The results can be seen on the company’s web site at https://www.businessforhome.org.

“Stemtech is very encouraged by the ranking as reported by Business For Home,” said John W. Meyer, President and COO of Stemtech. “Our improved ranking indicates that our revitalized marketing efforts are paying off and that we have increased our visibility substantially from the prior year. We intend to continue this momentum going forward. We feel that this positive reception has helped our Independent Business Partners by educating others that are interested in an income earning business opportunity. Additionally, our efforts have helped to educate consumers about the benefits of our all-natural, patent-protected plant-based products.”

About Stemtech Corporation

Stemtech Corporation, a leading nutraceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc. which was founded in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, the Company underwent an extensive executive reorganization, and continued operations under new leadership. Stemtech specializes in creating products and formulas that are patent-protected in the U.S. and in select international markets. The Company’s patented formulas help the release, circulation and migration of the body’s adult stem cells from its bone marrow. The Company markets its products under the following brands: RCM System, stemrelease3™, Stemflo® MigraStem®, OraStem® (Oral Health Care), and D-Fuze™ (EMF Blocker). Its products are all-natural and plant-based and manufactured under cGMP (Current Good Manufacturing Practices) under the auspices of the Dietary Supplement Health and Education Act (DSHEA). For more information, please visit www.stemtech.com.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest 10-K filed April 1, 2022. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time. Finally, the investing public is reminded that the only announcements or information about Stemtech Corporation which are condoned by the Company must emanate from the Company itself and bear our name as its Source.

For Further Information, Contact:
Frank J. Pena, 908 675-0581
fpena@stemtech.com

$STEK: Lets gooooooooooooooo STEMTECH


https://twitter.com/StockNewsBot2/status/1514589545995677697?s=20












GO $STEK

GNTW: effective April 14,2022 Globe Net Wireless Corp., GNTW, will change to Stemtech Corp., STEK:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Sold my position today - up 31%.

Anybody still in this?

Replay $GNTW Emerging Growth Conference.

Link to the video is here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166165192

Next Conference October 13
Register Here:
https://goto.webcasts.com/starthere.jsp?ei=1487781&tp_key=e2bca7d62c&sti=twitter

Who do you want to see present?
Tell us here:
www.EmergingGrowth.com/Conference

EGC 17 Replay:
$CANB
$PBIO
$GNTW
$AWX / $AWG
$PETV
$UCASU
$CLSH
$MARK
$CYDY

$GNTW Live on the Emerging Growth Conference in 30 minutes!

The Link to Register to Interact Live with the CEO's is here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166135334

Companies Presenting:
$AWG / $AWS / $AWP / $AWX
$PETV
$UCASU
$CLSH
$MARK
$CYDY

Presenting now or Previously:
$CANB
$PBIO

$GNTW Emerging Growth Conference 17 Starts in 1 hour!

The Link to Register to Interact Live with the CEO's is here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166135334

Companies Presenting:
$CANB
$PBIO
$GNTW
$AWG / $AWS / $AWP / $AWX
$PETV
$UCASU
$CLSH
$MARK
$CYDY

$GNTW StemTech CEO Live on the Emerging Growth Conference on September 29, 2021

Registration link here to interact Live:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166053788

Get Your Crypto on the Conference
email:
Conference@EmergingGrowth.com
or
Call the number here:
http://EmergingGrowth.com/Conference

New $GNTW article out: https://insiderfinancial.com/stemcell-nutraceutical-leader-stemtech-going-public-via-merger-with-otcmkts-gntw-globe-net-wireless-corp/182386/

$GNTW: D is gone



nice to see that.



Lets get a MTRT boost on it now



GO $GNTW

Won’t take much to make some big noise here

Agree $$

$GNTWD: Yes it is............


And its undiscovered.


Lets have them push out some PR's so more people realize they are now public.


Then we get some mega fireworks here



GO $GNTWD